Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 59 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/1/1999


1.		Phase II Trial of Bryostatin 1 for Metastatic Malignant Melanoma (Summary Last Modified 11/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				UCHSC-96309 NCI-T94-0171D, T94-0171

Last Modified: 11/1/1998


2.		Phase II Study of Bryostatin 1 for Advanced Melanoma (Summary Last Modified 11/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UPCC-1694 NCI-T95-0010D, T95-0010

Last Modified: 11/1/1999


3.		Phase II Study of Continuous-Infusion Bryostatin 1 for Chronic Myelogenous Leukemia (Summary Last Modified 11/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCHSC-96-344 NCI-T95-0015H, T95-0015

Last Modified: 10/1/2000


4.		Phase II Study of Bryostatin 1 in Relapsed non-Hodgkin's Lymphoma (Summary Last Modified 10/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				MDA-DM-95061 NCI-T95-0035D, NCT00002725, T95-0035

Last Modified: 4/27/2007


5.		Phase II Study of BRYO for Metastatic or Unresectable Renal Cell Carcinoma (Summary Last Modified 10/00)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MDA-DM-95166 NCI-T95-0085H, T95-0085

Last Modified: 4/1/2001


6.		Phase II Study of Bryostatin 1 in Relapsed Multiple Myeloma (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				WSU-C-1257 WSU-D-1257, NCI-T95-0062D, NCT00002907, T95-0062

Last Modified: 8/1/2000


7.		Phase II Study of Bryostatin 1 in Relapsed non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia with Addition of Vincristine for Disease Progression (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				WSU-C-1256 WSU-D-1256, NCI-T95-0058D, NCT00002908, T95-0058

Last Modified: 1/1/2000


8.		Phase II Open Label Study of Bryostatin in Patients with Low Grade Non-Hodgkin's Lymphoma (Summary Last Modified 01/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CRC-PHASE-II-PH2/031

Last Modified: 8/1/1998


9.		Phase II Trial of Bryostatin 1 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas (Summary Last Modified 08/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				MDA-NCNSC-96213 NABTC-NCNSC-96213, NCI-T96-0080, T96-0080

Last Modified: 3/1/2001


10.		Phase II Study of Tretinoin and Bryostatin 1 in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (Summary Last Modified 03/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				DFCI-96278 NCI-T96-0112, T96-0112

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute